Pancreastatin: Further evidence for its consideration as a regulatory peptide

Journal of Molecular Endocrinology

Volumn 16, Issue 1, 1996, Pages 1-8

  Sanchez Margalet V ^a   Lucas, M ^a   Goberna, R ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; GLUCAGON; INSULIN; PANCREASTATIN; PARATHYROID HORMONE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL TISSUE; CHROMAFFIN CELL; CONTROLLED STUDY; GLYCOGENOLYSIS; HUMAN; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRESS; SWINE;

EID: 0030059207     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.0.0160001     Document Type: Review

References (100)

1. Abood ME & Eberwine JH 1990 Characterization and regulation of a cDNA clone for rat pancreastatin. Biochemical and Biophysical Research Communications 167 1079-1085.
2. Ahren B, Lindskog S, Tatemoto K & Efendic S 1988 Pancreastatin inhibits insulin secretion and stimulates glucagon secretion in mice. Diabetes 37 281-285.
3. Arden SD, Rutherford NG, Guest PC, Curry WJ, Bailyes EM, Johnston CF & Hutton JC 1994 The post-translational processing of chromogranin A in the pancreatic islet: involvement of the eukaryote subtilism PC2. Biochemical Journal 298 521-528.
4. Berridge JM 1987 Inositol triphosphate and diacylglycerol: Two interacting second messengers Annual Reviews of Biochemistry 56 159-193.
5. Börglum-Jensen TD, Hoist JJ & Fahrenkrug J 1994 Secretion of pancreastatins from the porcine digestive tract. Scandinavian Journal of Gastroenterology 29 376-384.
6. Bretherton-Watt D, Valentino KL, Tatemoto K, Roth K, Polak JM & Bloom SR 1988 Pancreastatin distribution and plasma levels in the pig Peptides 9 1005-1014
7. Cryer PE, Wortsman J, Shah SD, Nowak AM & Deftos LJ 1991 Plasma chromogranin-A as a marker of sympathochromaffin activity in humans. American Journal of Physiology 260 E243-E246.
8. Curry WJ, Johnston CF, Shaw C & Buchanan KD 1990 Distribution and partial characterization of immunoreactivity to the putative C-terminus of rat pancreastatin. Regulatory Peptides 30 207-219.
9. Dimsdale JE, O'Connor DT, Ziegler M & Mills P 1992 Chromogranin A correlates with norepinephrine release rate. Life Sciences 51 519-525.
10. Drees BM & Hamilton JW 1992 Pancreastatin and bovine parathyroid cell secretion. Bone and Mineral 17 335-346.
11. Efendic S, Tatemoto K, Mutt V, Quan C, Chang D & Östenson CG 1987 Pancreastatin and islet hormone release. Proceedings of the National Academy of Sciences of the USA 84 7257-7260.
12. Eiden LE 1987 Is chromogranin A a prohormone? Nature 325 301.
13. Exton JH 1988 Role of phosphoinositides in the regulation of liver function. Hepatology 8 152-166.
14. Fasciotto BH, Gorr SU, DeFranco DJ, Levine MA & Cohn DV 1989 Pancreastatin, a presumed product of chromogranin A (secretory protein I) processing, inhibits secretion from porcine parathyroid cells in culture. Endocrinology 125 1617-1622.
15. Fasciotto BH, Gorr SU, Bourdeau AM & Cohn DV 1990 Autocrine regulation of parathyroid secretion inhibition of secretion by chromogranin-A (secretory protein-I) and potentiation of secretion by chromogranin-A and Pancreastatin antibodies. Endocrinology 127 1329-1335.
16. Flood JF, Morley JE & Tatemoto K 1988 Effects of systemic pancreastatin on memory retention. Peptides 9 1077-1080.
17. Funakoshi S, Tamamura H, Ohta M, Voshizawa K, Funakoshi A, Miyasaka K, Tateishi K, Tatemoto K., Nakano I, Yajima H & Fujii N 1989a Isolation and characterization of a tumor-derived human pancreastatin-related protein. Biochemical and Biophysical Research Communications 164 141-148,
18. Funakoshi A, Miyasaka K, Kitani K & Tatemoto K 1989b Effect of pancreastatin on pancreatic endocrine function in the conscious rat. Regulatory Peptides 24 225-231.
19. Funakoshi A, Miyasaka K, Kitani K, Tamamura H, Funakoshi S & Yajima H 1989c Bioactivity of synthetic C-terminal fragment of rat pancreastatin on endocrine pancreas. Biochemical and Biophysical Research Communications 158 844-849.
20. Funakoshi A, Miyasaka K, Nakamura R, Kitani K & Tatemoto K 1989d Inhibitory effect of pancreastatin on pancreatic exocrine secretion in the conscious rat. Regulatory Peptides 25 157-166.
21. Funakoshi A, Tateishi K, Shinozaki H, Miyasaka K, Ito T & Wakasugi H 1990a Plasma pancreastatin responses after intrajejunal infusion of liquid meal in patients with chronic pancreatitis. Digestire Diseases and Science 34 721-725
22. Funakoshi A, Tateishi K, Tsuru M, Jimi A, Wakasugi H, Ikeda Y & Kono A 1990b Pancreastatin producing cell line from human pancreatic islet cell tumor. Biochemical and Biophysical Research Communications 168 741-746.
23. Funakoshi A, Tateishi K, Shinozaki H, Matsumoto M & Wakasugi H 1990c Elevated plasma levels of pancreastatin (PST) in patients with non-insulin-dependent diabetes mellitus (NIDDM). Regulatory Peptides 30 159-164
24. Funakoshi A, Tateishi K, Tsuru M, Jimi A, Wakasugi H & Kono A 1991 Acetylcholine regulates pancreastatin secretion from the human pancreastatin-producing cell line (QGP-1N). Journal of Clinical Endocrinology and Metabolism 73 151-155.
25. Funakoshi A, Tateishi K, Tsuru M & Kono A 1992 Pertussis-toxin nonsensitive G-protein mediates cholinergic stimulation for secretion of pancreastatin and somatostatin from QGP-1N cells. Regulatory Peptides 37 1-7.
26. Funakoshi A, Tateishi K, Kitayama N, Jimi A, Matsuoka Y & Kono A 1993 Parallel secretion of PST and somatostatin from human pancreastatin producing cell line (QGP-1N). Pancreas 8 375-382.
27. Hashimoto T, Kogire M, Lluis F, Gomez G, Tatemoto K, Greeley GH Jr & Thompson JC 1990 Stimulatory effect of pancreastatin on gastric acid secretion in conscious dogs. Gastroenterology 99 61-65.
28. Helman LJ, Ahn TG, Levine MA, Allison A, Cohen PS, Cooper MJ, Cohn DV & Israel MA 1988 Molecular cloning and primary structure of human chromogranin A (secretory protein I) cDNA. Journal of Biological Chemistry 263 11559-11563,
29. Herzig KH, Louie DS, Tatemoto K & Chung OY 1992 Pancreastatin inhibits pancreatic enzyme secretion by presynaptic modulation of acetylcholine release. American Journal of Physiology 262 G113-G117.
30. Hoist JJ, Östenson GG, Harling H & Messell T 1990 Porcine pancreastatin has no effect on endocrine secretion fron the pig pancreas. Diabetologia 33 403-406.
31. Huttner WB & Benedum UM 1987 Chromogranin A and pancreastatin. Nature 325 305.
32. Hutton JC, Nielsen E & Kastern W 1988 The molecular cloning of the chromogranin A-like precursor of β-granin and pancreastatin from the endocrine pancreas. FEBS Letters 236 269-274.
33. Iancangelo AL, Affolter HU, Eiden LE, Herbert E & Grimes M 1986 Bovine chromogranin A sequence and distribution of its messenger RNA in endocrine tissues. Nature 323 82-86.
34. Iancangelo AL, Fischer-Colbrie R, Koller KJ, Brownstein MJ & Eiden LE 1988a The sequence of porcine chromogranin A messenger RNA demonstrates chromogranin A can serve as the precursor for the biologically active hormone, pancreastatin. Endocrinology 122 2339-2341.
35. Iancangelo AL, Okayama H & Eiden LE 1988b Primary structure of rat chromogranin A and distribution of its mRNA. FEBS Letters 227 115-121.
36. Iancangelo AL, Grimes M & Eiden LE 1991 The bovine chromogranin A gene-structural basis for hormone regulation and generation of biologically active peptides Molecular Endocrinology 5 1651-1660.
37. Inui A, Okita M, Inoue T, Sakatani N, Ova M, Morioka H, Oimomi M, Tatemoto K & Baba S 1989 Effects of pancreastatin on insulin and pancreatic polypeptide secretion in the dog. Endocrinologia Japonica 36 733-738.
38. Ishizuka J, Singh P, Greeley GH Jr, Towsend CM Jr, Cooper CW, Tatemoto K & Thompson JC 1988 A comparison of the insulinotropic and the insulin-inhibitory actions of gut peptides on newborn and adult rat islet cells. Pancreas 3 77-82.
39. Ishizuka J, Asadan I, Poston G-J, Lluis F, Tatemoto K, Greelev GH Jr & Thompson JC 1989 Effect of pancreastatin on pancreatic endocrine and exocrine secretion Pancreas 4 277-281.
40. Kar S, Bretherton-Watt D, Gibson SJ, Steel JH, Gentleman SM, Roberts GW, Valentino K, Tatemoto K, Ghatei MA, Bloom SR & Polak JM 1989 Novel peptide pancreastatin: its occurrence and codistribution with chromogranin A in the central nervous system of the pig. Journal of Comparative Neurology 288 627-639.
41. Kitayama N, Tateishi K, Funakoshi A, Miyasaka K, Shimazoe T, Kono A, Iwamoto N & Matsuoka Y 1994 Pancreastatin molecular forms in normal human plasma Life Sciences 54 1571-1578.
42. Konecki DS, Benedum UM, Gerdes HH & Huttner WB 1987 The primary structure of human chromogranin A and pancreastatin. Journal of Biological Chemistry 262 17026-17030.
43. Lamberts R, Schmidt WE & Creutzfeldt W 1990 Light and electron microscopical immunocytochemical localization of pancreastatin-like immunoreactivity in porcine tissues. Histochemistry 93 369-380.
44. Leduc R, Hendy GN, Seidah NG, Chrétien M & Lazure C 1990 Fragmentation of bovine chromogranin A by plasma kallikrein. Life Sciences 46 1427-1433.
45. Lewis JJ, Zdon MJ, Adrian TE & Modlin IM 1988 Pancreastatin: a novel peptide inhibitor of parietal cell secretion. Surgery 104 1031-1036.
46. Lewis JJ, Goldenring JR, Asher VA & Modlin JM 1989 Pancreastatin: a novel peptide inhibitor of parietal cell signal transduction. Biochemical and Biophysical Research Communications 163 667-673.
47. Lorinet AM, Tatemoto K, Laburthe M & Amiranoff B 1989 Pancreastatin inhibits insulin release from RIN m 5F cells: reversion by pertussis toxin. European Journal of Pharmacology 160 405-407.
48. Metz-Boutigue MH, Garcia-Sablone P, Hoghe-Angeletti R & Aunis D 1993 Intracellular and extracellular processing of chromogranin A. Determination of cleavage sites. European Journal of Biochemistry 217 247-257.
49. Miyasaka K, Funakoshi A, Nakamura R, Kitani K, Shimizu F & Tatemoto K 1989 Effects of porcine pancreastatin on postprandial pancreatic exocrine secretion and endocrine functions in the conscious rat. Digestion 43 204-211.
50. Miyasaka K, Funakoshi A, Kitani K, Tamamura H, Fujii N & Funakoshi S 1990a The importance of the C-terminal amide structure of rat pancreastatin to inhibit pancreatic exocrine secretion. FEBS Letters 263 279-280.
51. Miyasaka K, Funakoshi A, Yasunami Y, Nakamura R, Kitani K, Tamamura H, Funakoshi S & Fujii N 1990b Rat pancreastatin inhibits both pancreatic exocrine secretion and endocrine secretions in rats. Regulatory Peptides 28 189-198.
52. Miyasaka K, Funakoshi A, Kitani K, Tamamura H, Funakoshi S & Fujii N 1990c Inhibitory effect of pancreastatin on pancreatic exocrine secretion - pancreastatin inhibits central vagal nerve stimulation. Gastroenterology 99 1751-1756.
53. Mouland AJ, Bevan S, White JH & Hendy GN 1994 Human chromogranin A gene - Molecular cloning, structural analysis and neuroendocrine cell-specific expression. Journal of Biochemical Chemistry 269 6918-6926.
54. Nakano I, Funakoshi A, Miyasaka K, Ishida K, Makk G, Anguin P, Chang D & Tatemoto K 1989 Isolation and characterization of bovine pancreastatin. Regulatory Peptides 25 207-213.
55. Nishizuka Y 1984 The role of protein kinase C in cell surface signal transduction and tumor promotion. Nature 308 693-698.
56. O'Connor DT & Frigon RP 1984 Chromogranin A, the major catecholamine storage vesicle soluble protein. Journal of Biological Chemistry 259 3237-3247.
57. Ohneda A, Koizumi F & Ohneda M 1989 Effect of porcine pancreastatin on endocrine function of canine pancreas. Tohoku Journal of Experimental Medicine 159 291-298.
58. Östenson CG, Efendic S & Holst JJ 1989a Pancreastatin-like immunoreactivity and insulin are released in parallel from the perfused porcine pancreas. Endocrinology 124 2986-2990.
59. Östenson CG, Sandler S & Efendic S 1989b Effects of porcine pancreastatin on secretion and biosynthesis of insulin and glucose oxidation of isolated rat pancreatic islets. Pancreas 4 441-446.
60. Parmer RJ, Koop AH, Handa MT & O'Connor DT 1989 Molecular cloning of chromogranin A from rat pheochromocytoma cells. Hypertension 14 435-444.
61. Peiró E, Dégano P, Miralles P, Silvestre RA & Marco J 1991 Homologous pancreastatin inhibits insulin secretion without affecting glucagon and somatostatin release in the perfused rat pancreas. Regulatory Peptides 34 159-167.
62. Ravazzola M, Efendic S, Östenson CG, Tatemoto K, Hutton JC & Orci L 1988 Localization of pancreastatin immunoreactivity in porcine endocrine cells. Endocrinology 123 227-229.
63. Sánchez V, Calvo JR & Goberna R 1990 Glycogenolytic effect of pancreastatin m the rat. Bioscience Reports 10 87-91.
64. 2+-dependent mechanism. Biochemical Journal 284 659-662.
65. Sánchez-Margalet V & Goberna R 1993a Pancreastatin (33-49) enhances the priming effect of glucose in the rat pancreas. Experientia 49 551-552.
66. Sánchez-Margalet V & Goberna R 1993b Pancreastatin decreases plasma epinephrine levels in surgical stress in the rat. Peptides 14 797-799.
67. Sánchez-Margalet Y & Goberna R 1993c Pancreastatin, a new peptide associated to hypertension and hyperinsulinemia. Biologie Prospective, pp 575-580. 8° Colloque de Pont à Mousson. Ed MM Galteau, G Siest & J Henny. John Libbey Eurotext,
68. Sánchez-Margalet V & Goberna R 1994a Pancreastatin inhibits insulin-stimulated glycogen synthesis but not glycolysis in rat hepatocytes Regulatory Peptides 51 215-220.
69. Sánchez-Margalet V & Goberna R 1994b Pancreastatin activates pertussis toxin-sensitive guanylate cyclase and pertussis toxin-insensitive phospholipase C in rat liver membranes. Journal of Cellular Biochemistry 55 173-181.
70. Sánchez-Margalet V, Calvo JR, Lucas M & Goberna R 1992a Pancreastatin and its 33-49 C-terminal fragment inhibit glucagon-stimulated insulin in vivo. General Pharmacology 23 637-638.
71. 2+ in insulin secreting RIN m5F cells. Molecular and Cellular Endocrinology 88 129-133.
72. Sánchez-Margalet V, Calvo JR & Goberna R 1992c Glycogenolytic and hyperglycemic effect of 33-49 C-terminal fragment of pancreastatin in the rat in vivo. Hormone and Metabolic Research 24 455-457.
73. 2+ in rat hepatocytes involving both pertussis-toxin-sensitive and insensitive mechanisms. Biochemical Journal 294 439-442.
74. Sánchez-Margalet V, Valle M & Goberna R 1994a Receptors for pancreastatin in rat liver membranes: molecular identification and characterization by covalent cross-linking. Molecular Pharmacology 46 24-29.
75. Sánchez-Margalet V, Lucas M & Goberna R 1994b Pancreastatin activates protein kinase C by stimulating the formation of 1,2-diacylglycerol in rat hepatocytes. Biochemical Journal 303 51-54.
76. Sanchez-Margalet V, Valle M, Lobón JA, Maldonado A, Escobar F, Oliván J, Perez-Cano R & Goberna R 1995a Increased plasma pancreastatin-like immunoreactivity levels in non-obese patients with essential hypertension. Journal of Hypertension 13 251-258.
77. Sánchez-Margalet V, Valle M, Lobón JA, Escobar-Jimenez F, Perez-Cano R & Goberna R 1995b Plasma pancreastatin-like immunoreactivity correlates with plasma norepinephrine levels in essential hypertension. Neuropeptides 29 97-101.
78. Schmidt WE & Creutzfeldt W 1991 Pancreastatin: A novel regulatory peptide? Acta Oncologica 30 441-449.
79. Schmidt WE, Siegel EG, Kratzin H & Creutzfeldt W 1988 Isolation and primary structure of tumor-derived peptides related to human pancreastatin and chromogranin A. Proceedings of the National Academy of Sciences of the USA 85 8231-8235.
80. Schmidt WE, Stöckmann F, Roy-Choudhury A, Wilms H-M, Siegel E-G, Nustede R, Folsch UR & Creutzfeldt W 1989 Influence of CCK antagonist L-364, 718, pancreastatin (33-49) and a somatostatin analogue on camostate-induced rat pancreatic hypertrophy. Digestion 44 105-116.
81. Sekiya K, Ghatei MA, Minamino N, Bretherton-Watt D, Matsuo H & Bloom SR 1988 Isolation of human pancreastatin fragment containing the active sequence from a glucagonoma FEBS Letters 228 153-156.
82. Settleman J, Fonseca R, Nolan J & Hogue-Angeletti R 1985 Relationship of multiple forms of chromogranin. Journal of Biological Chemistry 260 1645-1651.
83. Silvestre RA, Peiro E, Miralles P, Villanueva ML & Marco J 1988 Effects of pancreastatin on insulin, glucagon and somatostatin secretion by the perfused rat pancreas. Life Sciences 42 1361-1367.
84. Simon JP & Aunis D 1989 Biochemistry of the chromogranin A family. Biochemical Journal 262 1-13
85. Simon JP, Bader MF & Aunis D 1989 Proteolytic processing of CGA in cultured chromaffin cells. Biochimica et Biophysica Acta 1051 123-130.
86. Syversen U, Mignon M, Bofils S, Kristensen A & Waldum HL 1993 Chromogranin A and pancreastatin-like immnunoreactivity in serum of gastrinoma patients. Acta Oncologica 32 161-165.
87. Syversen U, Jacobsen MB, O'Connor DT, Rönning K & Waldum HL 1994 Immunoassay for measurement of chromogranin A and pancreastatin-like immunoreactivity in humans: correspondence in patients with neuroendocrine neoplasia. Neuropeptides 26 201-206.
88. Tamamura H, Ohta M, Yoshizawa K & Ono Y 1990 Isolation and characterization of a tumor-derived human protein related to chromogranin-A and its in vitro conversion to human pancreastatin-48. European Journal of Biochemistry 191 33-39.
89. Tateishi K, Funakoshi A, Shinozaki H, Wakasugi H, Iguchi H, Shinozaki H, Abe M, Funakoshi S, Tamamura H, Yajima H & Matsuoka Y 1989 Plasma pancreastatin-like immunoreactivity in various diseases. Journal of Clinical Endocrinology and Metabolism 69 1305-1308.
90. Tateishi K, Miyasaka K, Shinozaki M, Funakoshi S, Matsuoka Y & Funakoshi A 1990 Pancreastatin-like immunoreactivity in urine. Journal of Clinical Endocrinology and Metabolism 71 812-815.
91. Tateishi K, Funakoshi A, Kitayama N & Matsuoka Y 1992a Interaction between phosphoinositide turnover and cyclic AMP pathway for the secretion of pancreastatin and somatostatin from QGP-1N cells. Biochemical and Biophysical Research Communications 185 1041-1047.
92. Tateishi K, Funakoshi A, Hashimoto K, Kitayama N & Matsuoka Y 1992b Degradation of human pancreastatin-52 by human kidney extract. Life Sciences 50 607-613.
93. Tatemoto K, Efendic S, Mutt V, Makk G, Feistner GJ & Barchas JC 1986 Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature 324 476-478.
94. Von Schonfeld J, Muller MK, Runzi M, Geling M, Neisius I, Kleimann J & Goebell H 1993 Pancreastatin - a mediator in the islet-acinar axis? Metabolism 42 552-555.
95. Watkinson A, O'Sullivan A, Burgoyne R & Dockray G 1990 Differential accumulation of catecholamines, proenkephalin-and CGA-derived peptides in the medium after chronic nicotine stimulation of cultured bovine adrenal chromaffin cells. Peptides 11 435-441.
96. Watkinson A, Jonsson AC, Davison M, Young J, Lee CM, Moore S & Dockray GJ 1991 Heterogeneity of chromogranin A-derived peptides in bovine gut, pancreas and adrenal medulla. Biochemical Journal 276 471-479.
97. Watkinson G, Rogers M & Dockray A 1993 Post-translational processing of chromogranin A: differential distribution of phosphorylated variants of pancreastatin and fragments 248-313 and 297-313 in bovine pancreas and ileum. Biochemical Journal 295 649-654.
98. Winkler H & Fischer-Colbrie R 1992 The chromogranin-A and chromogranin-B - the first 25 years and future perspectives. Neurosciences 49 497-528.
99. Wu HJ, Rozansky DJ, Parmer RJ, Gill BM & O'Connor DT 1991 Structure and function of the chromogranin A gene. Journal of Biological Chemistry 266 13130-13134.
100. Zhang J-X, Fasciotto BH, Darling DS & Cohn DV 1994 Pancreastatin, a chromogranin A-derived peptide, inhibits transcription of the parathyroid hormone and chromogranin A genes and decreases the stability of the respective messenger ribonucleic acids in parathyroid cells in culture. Endocrinology 134 1310-1316.